CVKD: Cadrenal Therapeutics Inc Financial Statements

Balance sheet, income statement, and cash flow statements for Cadrenal Therapeutics Inc (CVKD).

OverviewDividends

$24.04M Market Cap.

As of 03/13/2025 5:00 PM ET (MRY) • Disclaimer

CVKD Market Cap. (MRY)


CVKD Shares Outstanding (MRY)


CVKD Assets (MRY)


Total Assets

$10.12M

Total Liabilities

$2.68M

Total Investments

$0

CVKD Income (MRY)


Revenue

$0

Net Income

-$10.65M

Operating Expense

$10.96M

CVKD Cash Flow (MRY)


CF Operations

-$7.36M

CF Investing

-$6.54K

CF Financing

$8.98M

CVKD Balance Sheet (MRY)


Metric

2024

2023

2022

Total Assets

$10,123,533 (18.83%)

$8,519,250 (994.77%)

$778,174

Assets Current

$10,112,797 (19.08%)

$8,492,173 (1067.15%)

$727,596

Assets Non-Current

$10,736 (-60.35%)

$27,077 (-46.46%)

$50,578

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0

Shareholders Equity

$7,439,575 (-3.29%)

$7,692,375 (238.57%)

-$5,551,150

Property Plant & Equipment Net

$6,944 (-70.18%)

$23,285 (-47.78%)

$44,591

Cash & Equivalents

$10,017,942 (19.23%)

$8,402,500 (25685.61%)

$32,586

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0

Deferred Revenue

$0 (0%)

$0 (0%)

$0

Total Investments

$0 (0%)

$0 (0%)

$0

Investments Current

$0 (0%)

$0 (0%)

$0

Investments Non-Current

$0 (0%)

$0 (0%)

$0

Inventory

$0 (0%)

$0 (0%)

$0

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0

Trade & Non-Trade Payables

$1,502,468 (797.97%)

$167,319 (-58.68%)

$404,897

Accumulated Retained Earnings (Deficit)

-$25,722,783 (-70.67%)

-$15,071,415 (-124.47%)

-$6,714,329

Tax Assets

$0 (0%)

$0 (0%)

$0

Tax Liabilities

$0 (0%)

$0 (0%)

$0

Total Debt

$0 (0%)

$21,350 (-96.67%)

$640,706

Debt Current

$0 (0%)

$21,350 (-67.66%)

$66,016

Debt Non-Current

$0 (0%)

$0 (0%)

$574,690

Total Liabilities

$2,683,958 (224.59%)

$826,875 (-86.94%)

$6,329,324

Liabilities Current

$2,683,958 (224.59%)

$826,875 (-38.04%)

$1,334,477

Liabilities Non-Current

$0 (0%)

$0 (0%)

$4,994,847

CVKD Income Statement (MRY)


Metric

2024

2023

2022

Revenues

$0 (0%)

$0 (0%)

$0

Cost of Revenue

$0 (0%)

$0 (0%)

$0

Selling General & Administrative Expense

$6,753,726 (90.27%)

$3,549,514 (53.82%)

$2,307,503

Research & Development Expense

$4,205,013 (3.03%)

$4,081,349 (938.88%)

$392,859

Operating Expenses

$10,960,619 (43.60%)

$7,632,843 (182.53%)

$2,701,628

Interest Expense

$0 (0%)

$17,101 (-84.03%)

$107,105

Income Tax Expense

$0 (0%)

$0 (0%)

$0

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0

Consolidated Income

-$10,651,368 (-27.45%)

-$8,357,086 (-24.47%)

-$6,714,329

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0

Net Income

-$10,651,368 (-27.45%)

-$8,357,086 (-24.47%)

-$6,714,329

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0

Net Income Common Stock

-$10,651,368 (-27.45%)

-$8,357,086 (-24.47%)

-$6,714,329

Weighted Average Shares

$1,219,550 (-90.96%)

$13,491,980 (70.99%)

$7,890,507

Weighted Average Shares Diluted

$1,219,550 (-90.96%)

$13,491,980 (70.99%)

$7,890,507

Earning Before Interest & Taxes (EBIT)

-$10,651,368 (-27.71%)

-$8,339,985 (-26.23%)

-$6,607,224

Gross Profit

$0 (0%)

$0 (0%)

$0

Operating Income

-$10,960,619 (-43.60%)

-$7,632,843 (-182.53%)

-$2,701,628

CVKD Cash Flow Statement (MRY)


Metric

2024

2023

2022

Net Cash Flow from Investing

-$6,537 (-100.89%)

-$3,254 (-42.78%)

-$2,279

Net Cash Flow from Financing

$8,979,529 (-24.56%)

$11,903,491 (860.24%)

$1,239,635

Net Cash Flow from Operations

-$7,357,550 (-108.41%)

-$3,530,323 (-193.03%)

-$1,204,770

Net Cash Flow / Change in Cash & Cash Equivalents

$1,615,442 (-80.70%)

$8,369,914 (25585.61%)

$32,586

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0

Capital Expenditure

-$6,537 (-100.89%)

-$3,254 (-42.78%)

-$2,279

Issuance (Repayment) of Debt Securities

$0 (0%)

-$250,000 (-120.30%)

$1,231,685

Issuance (Purchase) of Equity Shares

$9,317,168 (-23.34%)

$12,153,491 (152774.10%)

$7,950

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0

Share Based Compensation

$1,419,039 (99.76%)

$710,381 (-23.45%)

$928,049

Depreciation Amortization & Accretion

$1,528 (-32.75%)

$2,272 (79.46%)

$1,266

CVKD Financial Metrics (MRY)


Metric

2024

2023

2022

Gross Margin

-

-

-

Profit Margin

-

-

-

EBITDA Margin

-

-

-

Return on Average Equity (ROAE)

-202.50% (-43.41%)

-141.20%

-

Return on Average Assets (ROAA)

-156.00% (-20.74%)

-129.20%

-

Return on Sales (ROS)

-

-

-

Return on Invested Capital (ROIC)

865.40% (-75.49%)

3531.00%

-

Dividend Yield

0% (0%)

0%

-

Price to Earnings Ratio (P/E)

-1.66 (-39.15%)

-1.19

-

Price to Sales Ratio (P/S)

-

-

-

Price to Book Ratio (P/B)

3.23 (157.86%)

1.25

-

Debt to Equity Ratio (D/E)

0.36 (237.38%)

0.11 (109.39%)

-1.14

Earnings Per Share (EPS)

-8.73 (-1308.06%)

-0.62 (27.06%)

-0.85

Sales Per Share (SPS)

0 (0%)

0 (0%)

0

Free Cash Flow Per Share (FCFPS)

-6.04 (-2204.58%)

-0.26 (-71.24%)

-0.15

Book Value Per Share (BVPS)

6.1 (970.18%)

0.57 (180.97%)

-0.7

Tangible Assets Book Value Per Share (TABVPS)

8.3 (1215.53%)

0.63 (537.37%)

0.1

Enterprise Value Over EBIT (EV/EBIT)

-2 (0%)

0

-

Enterprise Value Over EBITDA (EV/EBITDA)

-1.85 (-2698.48%)

-0.07

-

Asset Turnover

0 (0%)

0

-

Current Ratio

3.77 (-63.31%)

10.27 (1784.40%)

0.55

Dividends

$0 (0%)

$0 (0%)

$0

Free Cash Flow (FCF)

-$7,364,087 (-108.40%)

-$3,533,577 (-192.75%)

-$1,207,049

Enterprise Value (EV)

$19,673,924 (3455.74%)

$553,301

-

Earnings Before Tax (EBT)

-$10,651,368 (-27.45%)

-$8,357,086 (-24.47%)

-$6,714,329

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$10,649,840 (-27.73%)

-$8,337,713 (-26.22%)

-$6,605,958

Invested Capital

-$2,578,367 (-274.34%)

-$688,775 (-1429.25%)

$51,817

Working Capital

$7,428,839 (-3.08%)

$7,665,298 (1363.06%)

-$606,881

Tangible Asset Value

$10,123,533 (18.83%)

$8,519,250 (994.77%)

$778,174

Market Capitalization

$24,035,592 (149.45%)

$9,635,523

-

Average Equity

$5,259,074 (-11.16%)

$5,919,845

-

Average Assets

$6,827,107 (5.55%)

$6,467,990

-

Invested Capital Average

-$1,230,736 (-421.07%)

-$236,196

-

Shares

1,658,771 (-87.26%)

13,022,754 (58.93%)

8,193,875